ETR vs IRD · P/E 28, rev $12.95B vs rev $11.0M
Entergy Corporation (ETR) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Entergy Corporation (ETR) is a utilities - regulated electric company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported ETR revenue for 2025-12-31 was $12.95B. Net income was $1.77B. Revenue was up 9.0% from 2024-12-31 to 2025-12-31. ETR currently screens at market cap $50.71B and trailing P/E 28.3.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
ETR currently screens at market cap $50.71B and trailing P/E 28.3. IRD currently screens at market cap $35.7M.
Not investment advice. Open the ETR and IRD stock pages for the full models.
Not investment advice.